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Conclusions: PET/CT with low dose FDG provides good image 
quality and is a promising method for frequent monitoring of 
tumour response during CCRT, with reduced imaging dose and 
cost relative to standard PET/CT. A multidisciplinary 
approach in protocol development and image acquisition is 
essential to derive safe and efficient workflows. 
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Purpose/Objective: Magnetic resonance imaging (MRI) is 
increasingly becoming the preferred modality for 
radiotherapy treatment planning (RTP) of oropharynx and 
larynx cancer due to its excellent soft tissue contrast. Two 
dimensional (2D) outlines of these cancer regions from 
sequential axial MRI slices restrict the view of cancer regions 
with respect to other anatomical structures. Three 
dimensional (3D) volume reconstruction of cancer from 
contiguous MRI slices help oncologists to understand the 
complex structure of cancer with a greater degree of 
certainty. 3D views allow oncologists to understand the 
geometry, margin and specific morphological features of 
cancer regions from different angles. In this work we use a 
novel Level Set based method to automatically reconstruct 
2D oropharynx and larynx cancer boundaries from real MRI 
slices, for 3D visualisation and subsequent quantification. 
Materials and Methods: Axial gadolinium-enhanced T1-
weighted (T1+Gd) MRI scans were obtained for 2 patients 
with pharyngeal cancer. Contours of cancer region from 12 
contiguous MRI slices of oropharynx cancer and 7 contiguous 
MRI slices of larynx cancer were obtained, using our new 
automatic processing method, and then compared to the 
contours defined manually by clinical experts. Information 
from DICOM header, such as slice location, slice thickness and 
spacing in between slices, is used to reconstruct cancer in 
3D. For this, each contour is sampled into uniformly spaced 
100 points. These contours are stacked to produce the 3D 
dataset. Furthermore 2 additional contours are inserted in-
between real contours using a conventional spline 
interpolation technique. 3D cancer region is reconstructed 
from these contours using rectangular mesh. 
Results: The agreement between manual and automatic 
contours was estimated by the dice similarity coefficient 
(DSC). The DSC for all 19 slices is shown in Table1. It can be 
observed that most slices have value greater than 0.75, 
except the first or last slices where cancer region is small, 
hence the DSC value is small. The average DSC value for 2 
patients is 0.82. Fig.1 shows the 3D view of oropharynx and 
larynx cancer regions. From Fig.1 it is clear that 3D 
reconstructed cancer region from automatic and manual 
contours are comparable. The average error between 
automatic volume and manual volume1 is 4.62% using manual 
volume1 as reference. This error is 9.52% between manual 
volume1 and manual volume2 using manual volume1 as 
reference. The tumor-cut technique developed in 2012 for 3D 
brain tumour segmentation from T1+Gd MRI demonstrates 
volume error of 5.7% for two best cases which is comparable 
with this automatic technique. 
Conclusions: This reconstruction tool produces smooth, 
acceptable 3D surface for cancerous regions. The 
reconstructed surfaces provide oncologists with additional 
information not easily available from simple 2D MRI slices, 
about cancer regions. It is anticipated that this will lead to 
improved RTP.  
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Purpose/Objective: To implement a time effective solution 
to enable radiotherapy centres across the UK to remotely 
access and register a database of CT/CBCT images. The 
purpose was to facilitate the IGRT training and assessment of 
RTTs throughout the UK in order to provide QA for those 
clinical trials requiring IGRT. 
Materials and Methods: The process was initially 
implemented for the HYpofractionated Bladder Radiotherapy 
with or without Image guided aDaptive planning (HYBRID) 
Trial (CRUK/12/055), requiring CBCT analysis for plan of the 
day selection. The anonymised treatment datasets from 5 
patients, each containing 6 CT/CBCT images registered to the 
acquisition position, were imported into two vendor systems. 
Three patient cases (18 CBCT images) and the consensus plan 
of the day selection, consistent with the HYBRID Trial RT 
guidelines, were provided for training. 2 patient cases (12 
CBCT images) were provided for assessment. Detailed 
instructions and support were provided for participating 
centres in remotely accessing their vendor appropriate 
database.  
Individual centres were asked to complete an internet survey 
to obtain feedback on the process regarding image quality, 
usability, and general experience. 
Results: Remote training has been accessed by 10 
Radiotherapy centres across the UK recruiting patients into 
the HYBRID Trial. One centre completed the training as a 
group, while others accessed individually. The assessment 
required individuals to perform a bladder registration of CT 
and CBCT, and select the correct treatment plan from a 
library of 3 plans. This has been completed by 67 Individuals. 
54 individuals successfully completed the assessment cases 
with a pass mark of 83% (10/12 cases) or above on a first 
attempt; the remaining 13 achieved the pass mark on a 
second attempt following verbal feedback on the QA process. 
A pre-requisite of the adaptive trial was that centres had 
previous experience in CBCT soft tissue analysis for bladder 
cancer. The majority of centres (70%) reported individuals 
taking less than 1 hour to complete the training cases and 
86% of the respondents reported that the image quality 
across the systems was sufficient for them to effectively 
carry out the assessment. 
All centres responded that the training and assessment cases 
provided were sufficient to familiarise them with the trial 
protocol, and that the training and assessment had prepared 
them for plan selection within the trial. 
Conclusions: It is feasible and practical to use remote 
systems to train and assess IGRT competency for multi-centre 
clinical trials. This solution will be extended to UK clinical 
trials involving IGRT for other anatomical sites.  
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Purpose/Objective: In case of prostatic irradiation, dose 
constraints are designed for the whole rectum. A rectal sub-
region (RSR) may be especially involved in the risk of toxicity 
and may be highly predictive of toxicity. The goal of this 
work was to characterize this RSR. 
Materials and Methods: A total of 118 patients (pts) having 
received a total dose of 80Gy in prostate by IMRT with IGRT 
were included in this study. Rectal bleeding (RB) at three 
years was analyzed (≥ grade 1). A total of 31pts suffered from 
RB. Following a leave-one-out cross validation scheme, each 
patient was chosen as anatomical template of reference 
(ATR) towards which the anatomies of the 117 remaining 
patients were non-rigidly registered. The planned dose 
distributions of each patient were then propagated into the 
space of the ATR. A voxel-wise comparison (Mann-Whitney) 
was performed between the registered dose distributions of 
the two groups of pts (i.e. pts with or without RB). This 
enabled the segmentation of a RSR where the difference of 
dose between the two groups was significant (p<0.05). This 
RSR was then spatially characterized and its predictive 
performances were quantified by the area under the curve 
(AUC) resulting from logistic regression at each bin of its 
DVH.  
Results: The average volume of the identified RSRs was 
2.8cm3 (3.4% of the absolute rectal volume). The RSRs were 
mostly located in the anterior rectal wall (90% of the volume 
located at less than 16mm from the prostate) and in the 
inferior part of the rectum. In these RSRs, pts with RB 
received in average 3.8Gy more than the pts without RB. The 
AUC in the RSR was 71% whereas the AUC was 63% at the 
maximum in the other evaluated full rectum or rectal sub-
regions (anterior rectal wall only…).  
 
Conclusions: The identified RSR, likely involved in the risk of 
toxicity, is located in the anterior rectal wall, in the inferior 
part of the rectum. The RSR could be subject to specific dose 
constraints at the inverse planning step of IMRT to reduce the 
risk of toxicity, and be used to predict the risk of rectal 
bleeding. 
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Purpose/Objective: A general principle in patient radiation 
protection is to give the smallest effective dose in diagnostic 
or in therapy procedures. Patients benefiting from Breast 
Conservative Treatment (BCT) will all require adjuvant 
radiotherapy. This radiotherapy is usually performed with 
external beam radiation but can be, in selected cases, also 
delivered intra-operatively in a single session. The purpose of 
